Moreover, they used their approach to uncover new catalysts in low-throughput screens, yielding five distinct enzyme folds unlike any found in natural serine hydrolases.
Abide Therapeutics is mining one such enzyme superfamily, the serine hydrolases (SHs). Comprising over 200 members, the SH enzyme family has considerable untapped potential and has already yielded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback